|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| ASSETS | |||||
| Current assets: | |||||
| Cash and cash equivalents | |||||
| Prepaid expenses – current | |||||
| Total Current Assets | |||||
| Deferred offering costs | |||||
| Prepaid expenses – non-current | |||||
| Cash and cash equivalents held in Trust Account | |||||
| Total Assets | |||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT | |||||
| Current liabilities: | |||||
| Accrued offering costs | |||||
| Accrued expenses | |||||
| Accounts payable | |||||
| Promissory note – related party | |||||
| Due to related party | |||||
| Total Current Liabilities | |||||
| Deferred underwriting commissions | |||||
| Total Liabilities | |||||
| Commitments and Contingencies (Note 7) | |||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 17,250,000 shares issued and outstanding at an approximate redemption value of $10.39 and $10.20 at June 30, 2026 and December 31, 2025, respectively | |||||
| Shareholders’ Deficit | |||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at June 30, 2026 and December 31, 2025 | |||||
| Common stock, value, issued | |||||
| Class A Ordinary Shares | |||||
| Class B Ordinary Shares | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total Shareholders’ Deficit | |||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
Loading...
